If qbrexza is covered by insurance companies, then 30m annual revenue with 12 refills a year and $690 per unit, that's 3623 patients onboarded. If we consider it 30m with a patient using qbrexza once a year, that's 43478 patients.
if we extrapolate this to sofdra, it seems inconsistent with some figures bandied about.
how much do people realistically believe will use sofdra over qbrexza? Similar numbers, double? Triple?
If qbrexza is covered by insurance companies, then 30m annual...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
-0.005(1.75%) |
Mkt cap ! $441.0M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 27.5¢ | $1.258M | 4.481M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 102028 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 200589 | 6 |
View Market Depth
| Last trade - 16.10pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
27.5¢ |
Change
-0.005 ( 3.37 %) |
||||
| Open | High | Low | Volume | ||
| 28.5¢ | 29.0¢ | 27.5¢ | 2415639 | ||
| Last updated 15.59pm 05/06/2024 ? | |||||
| BOT (ASX) Chart |